10 Apr 2007 |
Caliper Life Sciences to Explore Novel Indications for Drug Candidates
|
07 Apr 2007 |
Stratagene Signs Definitive Agreement to Be Acquired by Agilent Technologies
|
06 Apr 2007 |
JDRF To Collaborate with MediGene to Develop an Antigen-Specific Immunotherapeutic for Type I Diabetes
|
05 Apr 2007 |
pSivida signs A$203 million (US$165 million)
|
05 Apr 2007 |
pSivida signs A$203 million (US$165 million)
|
05 Apr 2007 |
AVEO enters into Worldwide License and Development Agreement with Schering-Plough for AV-299, AVEO's Novel Anti-HGF Antibody
|
05 Apr 2007 |
Innocoll Receives FDA Approval to Commence Phase 2 Clinical Development with its CollaRx(R) BUPIVACAINE IMPLANT for the Management of Post-operative Pain
|
05 Apr 2007 |
CytoGenix Announces Successful Testing of synDNA(TM) Vaccine for Avian Influenza Virus
|
05 Apr 2007 |
Boca Pharmacal Receives FDA Approval for Generic Pamine(R) and Pamine(R) Forte Tablets
|
04 Apr 2007 |
Pharmexa and Affitech enter into an exclusive license agreement to promote Diabody technology
|
04 Apr 2007 |
IMPAX Announces FDA Approval of Generic Corzide
|
03 Apr 2007 |
Roche acquires THP to expand its therapeutic antibody research
|
03 Apr 2007 |
Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data Show
|
03 Apr 2007 |
Senetek PLC Grants Paid Up License to Valeant Pharmaceuticals
|
03 Apr 2007 |
CSL Biotherapies Submits BLA to Introduce Flu Vaccine to U.S. Market
|
31 Mar 2007 |
Astellas Licenses Regeneron“s Velocimmune(R) Technology For Discovering Human Monoclonal Antibodies
|
31 Mar 2007 |
Takeda to Obtain Development and Commercial Rights
|
31 Mar 2007 |
CanBas and Takeda to Sign the Collaboration Agreement
|
31 Mar 2007 |
LG Life Sciences and Takeda Announce Collaboration
|
30 Mar 2007 |
Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
|
30 Mar 2007 |
Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
|
30 Mar 2007 |
Ad hoc: Evotec to Acquire Neuro3d
|
29 Mar 2007 |
Oxford BioMedica and Sanofi-Aventis Enter Global Licensing Agreement to Develop and Commercialise TroVax for Cancer
|
29 Mar 2007 |
MorphoSys and Astellas Enter Antibody Partnership - Deal Seals MorphoSys's Third Japanese Pharmaceutical Alliance
|
29 Mar 2007 |
Wockhardt receives US FDA approval for anti-inflammatory injection
|